KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Recursion Pharmaceuticals (RXRX) Long-Term Debt Issuances (2020)

Recursion Pharmaceuticals' Long-Term Debt Issuances history spans 1 years, with the latest figure at $400000.0 for Q2 2020.

  • For Q2 2020, Long-Term Debt Issuances changed N/A year-over-year to $400000.0; the TTM value through Mar 2021 reached $400000.0, changed N/A, while the annual FY2020 figure was $6.4 million, 46.16% down from the prior year.
  • Long-Term Debt Issuances reached $400000.0 in Q2 2020 per RXRX's latest filing, down from $6.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $6.0 million in Q1 2020 to a low of $400000.0 in Q2 2020.